Biotech · Private company
Galecto Biotech AB
Track this companyFree. Adds Galecto Biotech AB to your Dealase workspace and tells you when its record changes.
Clinical trials32 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- GB0139Phase 2 · Idiopathic Pulmonary Fibrosis (IPF)ClinicalTrials.gov · fetched Nov 12, 2026
- GB2064Phase 2 · MyelofibrosisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- GB1211 and Pembrolizumab Versus Pembrolizumab and Placebo in Patients With Metastatic Melanoma and Head and Neck Squamous Cell CarcinomaPHASE2 · ACTIVE_NOT_RECRUITING · started Feb 29, 2024ClinicalTrials.gov NCT05913388 · fetched Nov 12, 2026
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral GB2064 in Participants With MyelofibrosisPHASE2 · ACTIVE_NOT_RECRUITING · started Jun 9, 2021ClinicalTrials.gov NCT04679870 · fetched Nov 12, 2026
- A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)PHASE2 · COMPLETED · started Feb 19, 2019ClinicalTrials.gov NCT03832946 · fetched Nov 12, 2026